Search results | molecular diagnostics

Reports

Molecular Diagnostics Partnering Terms and Agreements

The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals.

Cancer Diagnostics Partnering Terms and Agreements

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract documents Top cancer diagnostics deals by value   The more »

Diagnostic Imaging Partnering Terms and Agreements

The Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies.

Insights

Molecular diagnostics partnering: recent life science trends 2009-2014

Molecular diagnostics is the use of molecular biology for medical testing and clinical applications. This discipline determines how genes and proteins interact in a cell. This partnering article reflects on the recent life science trends in the molecular diagnostics technology arena.

Diagnostics partnering: recent life science trends 2009-2014

Diagnostics are subject to numerous partnering deals every year. Here we provide a review of recent life science trends in deal making activity

Companion diagnostics

Companion diagnostics are assays that measure levels of proteins, genes or specific mutations….

Diagnostics

Diagnostics are any kind of medical test performed to aid in the diagnosis or detection of disease.

J&J receives bids for Ortho Clinical Diagnostics unit

Some of the world’s largest private equity firms have made preliminary offers for Johnson & Johnson’s Ortho Clinical Diagnostics unit

Dealtalk: Johnson & Johnson kicks off $5 billion clinical diagnostics unit sale

In dealtalk, Johnson & Johnson launched a sale process for its Ortho Clinical Diagnostics unit for around $5 billion.

Big pharma company Roche earmarks $300m for diagnostics HQ

Roche, a big big pharma company has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, US, with the creation of up to 100 jobs by 2017

Abbott Laboratories

Abbott Laboratories is a top pharmaceutical company based in Illinois, USA

Danaher, Blackstone pursue joint bid for J&J unit-sources

Danaher has teamed up with Blackstone Group to bid for Johnson & Johnson’s diagnostics unit, which makes blood screening equipment and laboratory blood tests

Healthcare M&A trends of 2013 so far

The healthcare sector in 2013 continues to adjust to a new environment of sluggish economic growth, budget constraints, reimbursement challenges, higher regulatory hurdles, and the uncertainties surrounding healthcare reform. Just recently, the European Parliament recently approved, by an overwhelming margin, a tightening up of CE-mark pre-market authorizations and post-mark surveillance of medical devices

Events

Sorry, your search returned no results.


Deals

Merck grants pharma licensing rights to HTG Molecular Diagnostics for breast cancer markers

In a pharma licensing deal HTG Molecular Diagnostics has been granted a non-exclusive license to develop, manufacture, and commercialize breast cancer diagnostic tests under Merck’s patent portfolio.

Almac Diagnostics in collaboration with Pfizer and PETACC3 Translational Research Working Party for molecular subtyping and biomarker identification in colorectal cancer

The aims of the study are to identify molecular subtypes in colorectal cancer and to identify new drug targets in treatment resistant patients.

Collaboration and co marketing agreement for 3D molecular profiles for tissue characterization

Protea Biosciences and InSphero have entered into a collaboration that will combine each company’s respective 3D technology.

Exosome Diagnostics gets $27 million in Series B financing

Exosome Diagnostics announced the initial close of its Series B financing round with the raising of $27 million.

Ventana and Bayer ink pharma alliance for development of companion diagnostics

Ventana Medical Systems has entered into a multi-year pharma alliance with Bayer Pharma to develop companion diagnostics, with a focus on immunohistochemistry (IHC), across Bayer’s portfolio of targeted therapy projects.

Collaborative R&D for application of next generation sequencing test for clinical molecular diagnostic testing

GENEWIZ and Beijing ACCB Biotech Ltd. announced a collaboration for the application of next generation sequencing tests toward the advancement of clinical molecular diagnostics.

Eli Lilly in companion diagnostics agreement with Qiagen

QIAGEN has entered into a master collaboration agreement with Eli Lilly, the top pharmaceutical company,and Company for the development and commercialization of companion diagnostics for pairing with Lilly investigational and approved medicines across all therapeutic areas.

Big pharma company Roche earmarks $300m for diagnostics HQ

Roche, a big big pharma company has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, US, with the creation of up to 100 jobs by 2017

Life Technologies signs agreement with GSK Biologicals, seeking expanded use of platform technologies into companion diagnostics

Agreement with GlaxoSmithKline Biologicals to develop a diagnostic to be used as a companion test with a GSK candidate cancer immunotherapy. 

Roche and IQuum’s m&a transaction for $450 million

Roche enters into a m&a with U.S. diagnostics company IQuum in $450 million deal